Eximias raises $63.5 million

Cancer company Eximias (Berwyn, Penn.) raised $63.5 million in a series D round co-led by Cross Atlantic Partners and Quaker BioVentures. Other investors included New Enterprise Associates; OrbiMed; Birchmere; Easton Hunt Capital; Cross Atlantic Capital; Pacific Rim Ventures; and Emerging Technology Partners. Ferghana Securities served as placement agent and advisor. John Cassis, a partner at Cross Atlantic Partners; Brenda Gavin, managing partner at Quaker BioVentures; Michael Sheffery, general partner at Orbimed; and M. James Barrett, general partner at New Enterprise Associates, joined Eximias' board ...